Peptides for Menopause: Hot Flashes, Bone Loss, Skin & Mood
Last updated: 2026-03-27
Menopause affects every woman, typically occurring between ages 45-55 in the UK, with an average age of 51. The decline in oestrogen production causes a wide range of symptoms including vasomotor symptoms (hot flashes, night sweats), bone density loss, skin ageing, mood changes, and cognitive fog. While HRT remains the gold-standard treatment per NICE NG23, some women cannot or choose not to use HRT, creating interest in alternative approaches.
Peptide research has identified several candidates that may address specific menopause-related concerns. GHK-Cu and cosmetic peptides target skin ageing, growth hormone secretagogues may help counteract the decline in GH that accompanies menopause, and kisspeptin research explores the neurological basis of vasomotor symptoms.
Importantly, no peptides are approved alternatives to HRT. The menopausal transition involves complex hormonal changes that peptides cannot fully replicate. However, understanding peptide research may inform future therapeutic developments.
All information is educational. Menopause management should follow NICE NG23 under GP or menopause specialist guidance.
What this guide is — and what to do first
Peptide research for this condition is interesting, but it is not the first thing to consider. The blocks below cover standard UK care, when to see your GP, what licensed treatments exist, and how the peptide evidence actually stacks up.
Standard care first
NICE NG23 sets out menopause care. Vasomotor symptoms: HRT is first-line for women without contraindications — combined oestrogen-progestogen if uterus present, oestrogen alone if hysterectomised. Local vaginal oestrogen for genitourinary symptoms (effective and safe even with systemic HRT contraindications). Non-HRT options for vasomotor symptoms: SSRIs (paroxetine, venlafaxine off-label), gabapentin, CBT. Bone protection: HRT, bisphosphonates, calcium and vitamin D. Lifestyle: regular weight-bearing exercise, smoking cessation, alcohol moderation, balanced diet.
When to speak to your GP
See your GP if you have menstrual irregularity, hot flushes, night sweats, vaginal dryness, low mood, sleep disruption, or joint pain in your 40s-50s — menopause should be diagnosed and discussed. Same-week assessment for any bleeding after menopause (postmenopausal bleeding is a red flag), severe mood changes with suicidal thoughts, or symptoms that significantly impair work or relationships. Specialist menopause clinic referral for complex cases or HRT contraindications.
UK-approved treatments for this condition
HRT is NICE first-line: oestrogen (oral, transdermal patch, gel, spray), combined with cyclical or continuous progestogen if uterus present. Specific products: Femoston, Elleste Duet, Kliovance, oestradiol patches, Sandrena gel. Tibolone is licensed as a single-agent alternative. SSRIs / SNRIs for vasomotor symptoms in women with HRT contraindications (paroxetine, citalopram, venlafaxine off-label but evidence-supported). Gabapentin as an alternative for vasomotor symptoms. Vaginal oestrogen (estriol/estradiol cream, pessary, ring) for genitourinary symptoms. CBT for hot flushes and low mood, NHS-available via Talking Therapies. No peptide is MHRA-licensed for any menopause indication.
What the peptide evidence actually says
| Peptide | Human evidence | UK status | Honest verdict |
|---|---|---|---|
| GHK-Cu (topical cosmetic) | Moderate for skin appearance | Cosmetic ingredient | Topical cosmetic use is supported by skincare RCTs; not a menopause treatment. Reasonable as part of a skincare routine. |
| CJC-1295 / Ipamorelin | None for menopause | Unlicensed; WADA S2 | GH-axis claims for menopausal body composition not supported by trial data. |
| Kisspeptin-10 | Limited Imperial research | Research only | Mechanistic interest in vasomotor symptoms; not clinically available. |
| Epitalon | Russian studies only | Unlicensed | Longevity claims; no replicated Western data and no menopause-specific evidence. |
How Peptides May Help
Growth hormone levels decline significantly during menopause, contributing to reduced muscle mass, increased abdominal fat, decreased bone density, and skin thinning. GH secretagogues (CJC-1295, Ipamorelin, Sermorelin) are researched for their potential to counteract this age-related GH decline, though evidence specifically in menopausal women is limited.
GHK-Cu has been extensively researched for skin ageing — a major concern for menopausal women as oestrogen decline accelerates collagen loss (up to 30% in the first 5 years). GHK-Cu stimulates collagen synthesis, fibroblast activity, and skin remodelling through multiple pathways.
Kisspeptin neurons in the hypothalamus are directly involved in thermoregulation and are thought to play a role in hot flashes. Research at Imperial College London explores whether kisspeptin modulation could address vasomotor symptoms at their neurological source rather than through hormonal replacement.
Researched Peptides
GHK-Cu
High
Stimulates collagen synthesis; combats accelerated skin ageing from oestrogen decline
CJC-1295 + Ipamorelin
Moderate
GH optimisation to counteract menopause-related GH decline; supports body composition
Epitalon
Moderate
Telomerase activation researched for cellular ageing; may complement anti-ageing approaches
Kisspeptin-10
Low
Research into thermoregulation and vasomotor symptoms; highly investigational
BPC-157
Low
May support gut health and general tissue repair during menopausal transition
Peptide Comparisons
HRT remains the most effective treatment for menopause symptoms per NICE guidelines. No peptide approach can replicate the comprehensive hormonal support of properly prescribed HRT. Peptide research may offer complementary approaches for specific concerns like skin ageing (GHK-Cu) or GH decline.
Safety Considerations
No peptides are approved for menopause treatment. HRT is the gold-standard treatment and should be discussed with a GP or menopause specialist before considering any alternatives. Women should not delay or avoid HRT based on peptide research, as the cardiovascular and bone-protective benefits of HRT are well-established.
GH secretagogues can affect glucose metabolism and should be used cautiously in women with diabetes risk factors, which increase during menopause. Any peptide use during the menopausal transition should be discussed with a healthcare provider who understands both the hormonal changes and the research peptide landscape.
Frequently Asked Questions
Conclusion
Peptide research relevant to menopause is at an early stage, with the most practical current application being GHK-Cu for skin ageing. GH secretagogues may help address the GH decline component of ageing, and kisspeptin research into vasomotor symptoms is scientifically promising but far from clinical application. HRT remains the recommended first-line treatment per NICE NG23.
*This information is for educational purposes only. Menopause management should follow NICE NG23 guidelines. Speak to your GP or a British Menopause Society-registered specialist.*
Medical Disclaimer
The information provided on this page is for educational and research purposes only. The peptides discussed are not approved medications for the conditions described. This content does not constitute medical advice. Always consult a qualified healthcare professional before considering any peptide or supplement.
Related Categories
Explore Other Guides
Peptides for Tendon Injuries & Repair
Tendon injuries—whether from sports, repetitive strain, or age-related degeneration—represent some of the most challengi...
Peptides for Fat Loss & Weight Management
The search for effective weight management solutions has led researchers to investigate various peptides that may influe...
Peptides for Muscle Growth & Recovery
The pursuit of enhanced muscle growth, improved recovery, and optimised body composition has driven significant interest...
Peptides for Anti-Ageing & Longevity
The science of ageing has advanced dramatically, moving from inevitable decline to a potentially modifiable process. Pep...
Peptides for Cognitive Enhancement & Brain Health
Cognitive enhancement—improving memory, focus, mental clarity, and brain health—has become a major area of interest in p...
Peptides for Immune Support & Function
The immune system's complexity and critical role in health has made it a major focus of peptide research. From thymic pe...
Peptides for Sexual Health & Function
Sexual health encompasses physical function, desire, satisfaction, and psychological wellbeing—all influenced by complex...
Peptides for Joint Health & Cartilage Repair
Joint health issues—including osteoarthritis, cartilage degeneration, and chronic joint pain—affect millions of people w...
Peptides for Sleep Optimization & Sleep Quality
Sleep is fundamental to health, affecting everything from cognitive function and immune defence to metabolic regulation ...
Peptides for Blood Sugar Management & Glycaemic Control
Blood sugar dysregulation affects hundreds of millions of people globally. Type 2 diabetes alone impacts over 530 millio...
Peptides for Anxiety & Stress Reduction
Anxiety and chronic stress affect millions of people worldwide and represent a growing area of unmet clinical need. Whil...
Peptides for Athletic Performance & Recovery
The intersection of peptide science and sports performance has become one of the most actively researched — and debated ...
Peptides for Heart Health & Cardiovascular Support
Cardiovascular disease remains the leading cause of death worldwide, accounting for approximately 17.9 million deaths an...
Peptides for Liver Health & Detoxification
The liver is the body's primary metabolic and detoxification organ, responsible for over 500 essential functions includi...
Peptides for Autoimmune Conditions & Immune Modulation
Autoimmune diseases — conditions in which the immune system mistakenly attacks the body's own tissues — affect approxima...
Peptides for Post-Surgery Recovery & Wound Healing
Post-surgical recovery is a complex physiological process involving haemostasis, inflammation, proliferation, and remode...
Peptides for Skin Pigmentation & Tanning
Skin pigmentation is primarily determined by the production and distribution of melanin — a family of pigments synthesis...
Peptides for Fertility & Reproductive Health
Fertility and reproductive health are regulated by an intricate hormonal network centred on the hypothalamic-pituitary-g...
Peptides for Weight Loss
Weight loss has become one of the most significant public health priorities in the United Kingdom. According to NHS Engl...
Peptides for Diabetes & Blood Sugar Control
Type 2 diabetes is one of the most significant health challenges facing the United Kingdom. Diabetes UK estimates that a...
Peptides for Bodybuilding & Muscle Gain
Bodybuilding and strength sports have long driven interest in compounds that may enhance muscle growth, accelerate recov...
Peptides for Knee Pain & Joint Support
Knee pain is one of the most prevalent musculoskeletal complaints worldwide, affecting an estimated 25% of adults and ac...
Peptides for Back Pain & Spinal Health
Back pain is the leading cause of disability worldwide and one of the most common reasons for GP consultations in the Un...
Peptides for IBS & Digestive Disorders
Irritable bowel syndrome (IBS) affects an estimated 10-15% of the UK population and is the most common functional gastro...
Peptides for Depression & Mood Support
Depression is one of the most prevalent mental health conditions globally, affecting an estimated 5% of the adult popula...
Peptides for PCOS (Polycystic Ovary Syndrome)
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder affecting women of reproductive age, with an esti...
Peptides for Chronic Fatigue & CFS/ME
Chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME) or ME/CFS, is a complex, debilitating condi...
Peptides for Neuropathy & Nerve Health
Neuropathy — damage or dysfunction of peripheral nerves — affects an estimated 2-3% of the general population, with prev...
Peptides for Thyroid Health & Function
Thyroid disorders are among the most common endocrine conditions in the United Kingdom, affecting an estimated 2-5% of t...
Peptides for Respiratory & Lung Health
Respiratory disease is the third leading cause of death in the United Kingdom, with chronic obstructive pulmonary diseas...
Peptides for Long COVID & Post-Viral Syndrome
Long COVID — formally known as post-COVID-19 syndrome — affects an estimated 1.9 million people in the UK (ONS, 2024). D...
Peptides for Fibromyalgia & Chronic Pain
Fibromyalgia is a chronic condition characterised by widespread musculoskeletal pain, fatigue, sleep disturbance, and co...
Peptides for Lyme Disease & Post-Treatment Syndrome
Lyme disease, caused by the spirochaete bacterium *Borrelia burgdorferi* (and related species *B. garinii* and *B. afzel...
Peptides for Erectile Dysfunction & Sexual Performance
Erectile dysfunction (ED) affects an estimated 4.3 million men in the UK, with prevalence increasing significantly after...
Peptides for Infertility: Male & Female Fertility Research
Infertility affects approximately 1 in 7 couples in the UK, with roughly equal contributions from male and female factor...
Peptides for Osteoarthritis & Joint Health
Osteoarthritis (OA) affects over 10 million people in the UK and is the most common form of arthritis, characterised by ...
Peptides for Migraine Prevention
Migraine affects approximately 10 million people in the UK and is the third most common disease globally. While recent C...
Peptides for Neuropathic Pain & Nerve Damage
Neuropathic pain — caused by damage or dysfunction of the nervous system itself — affects approximately 7-8% of the UK p...
Peptides for Disc Degeneration & Back Pain
Intervertebral disc degeneration is the most common cause of chronic lower back pain, affecting an estimated 80% of adul...
Peptides for Frozen Shoulder Recovery
Frozen shoulder (adhesive capsulitis) affects 2-5% of the general population and up to 20% of people with diabetes. It c...
Peptides for Bone Density & Osteoporosis Prevention
Osteoporosis affects approximately 3.5 million people in the UK, causing over 500,000 fragility fractures annually. The ...
Peptides for Cardiovascular Health & Heart Protection
Cardiovascular disease (CVD) remains the UK's leading cause of death, accounting for approximately 160,000 deaths annual...
Peptides for Thyroid Function & Support
Thyroid disorders affect approximately 2-5% of the UK population, with hypothyroidism being far more common than hyperth...
Musculoskeletal Recovery — peptide research hub
Peptide research that touches the musculoskeletal system spans tendon and ligament repair, joint inflammation, cartilage...
Metabolic and Weight — peptide research hub
The metabolic-and-weight space is the most heavily-licensed corner of peptide medicine in the UK — semaglutide (Wegovy /...
Neuro and Mood — peptide research hub
Neuropeptide research is dominated by compounds developed in Russia and Eastern Europe with decades of regional clinical...
Immune and Inflammation — peptide research hub
Immune-modulating and anti-inflammatory peptides are an active research area with thin human-trial data for the conditio...
Skin and Aesthetics — peptide research hub
Cosmetic peptide use splits into two very different categories: topical peptides (GHK-Cu, Matrixyl, Argireline, SNAP-8) ...
Hormonal and Reproductive — peptide research hub
Hormonal and reproductive-health peptides span fertility hormones (gonadorelin, GnRH analogues), menopause-related resea...
Peptides for Hair Growth & Follicle Health
Hair loss affects millions of people worldwide, with androgenetic alopecia (pattern baldness), telogen effluvium, and al...
Peptides for Skin Health & Anti-Ageing
Peptides have revolutionised modern skincare, offering science-backed approaches to anti-ageing, wound healing, and skin...
Peptides for Gut Health & Digestive Repair
Gastrointestinal health is fundamental to overall wellbeing, influencing everything from nutrient absorption and immune ...
Peptides for Wrinkle Reduction & Skin Rejuvenation
Cosmetic peptides have revolutionised the skincare industry, offering targeted mechanisms for addressing different types...
Peptides for Skin Firmness & Collagen Restoration
Skin firmness depends fundamentally on the dermal extracellular matrix—a dense network of collagen, elastin, and glycosa...
Peptides for Wound Healing & Tissue Repair
Wound healing is a complex, multi-phase biological process involving inflammation, proliferation, and remodelling. Chron...
Peptides for Inflammation & Immune Modulation
Chronic inflammation underlies many of the most prevalent health conditions—from autoimmune disorders and cardiovascular...
Peptides for Bone Health & Fracture Recovery
Bone health is a critical concern across the lifespan—from fracture healing in athletes and trauma patients to osteoporo...
Peptides for Anxiety & Stress Management
Anxiety disorders are among the most prevalent mental health conditions globally, affecting approximately 284 million pe...
Peptides for Energy & Metabolic Optimisation
Energy metabolism—the complex system by which cells convert nutrients into usable energy—underlies virtually every aspec...